CORTEXYME

Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.

CORTEXYME

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2012-01-01

Address:

South San Francisco, California, United States

Country:

United States

Website Url:

http://www.cortexyme.com

Total Employee:

11+

Status:

Active

Total Funding:

225 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome

Similar Organizations

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

clene-nanomedicine-logo

Clene Nanomedicine

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis Precision Medicines offers drug development services.

theravance-biopharma-logo

Theravance Biopharma

Theravance Biopharma is a biopharmaceutical company with one approved product.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Advisors List

christopher-senner_image

Christopher Senner Board Member @ Cortexyme
Board_member
2019-03-01

margi-mcloughlin_image

Margi McLoughlin Board Member @ Cortexyme
Board_member
2015-01-01

kevin-young_image

Kevin Young Board Member @ Cortexyme
Board_member
2019-02-01

not_available_image

David Lamond Board Member @ Cortexyme
Board_member

stephen-dominy_image

Stephen Dominy Board Member @ Cortexyme
Board_member
2015-12-01

casey-lynch_image

Casey Lynch Board Chairman @ Cortexyme
Board_member
2013-01-01

una-ryan_image

Una Ryan Board Member @ Cortexyme
Board_member
2019-01-01

Current Employees Featured

casey-lynch_image

Casey Lynch
Casey Lynch Co-Founder & CEO @ Cortexyme
Co-Founder & CEO
2013-01-01

robert-galemmo_image

Robert Galemmo
Robert Galemmo VP Drug Discovery @ Cortexyme
VP Drug Discovery
2017-01-01

stephen-dominy_image

Stephen Dominy
Stephen Dominy Chief Scientific Officer @ Cortexyme
Chief Scientific Officer
2016-04-01

christopher-lowe_image

Christopher Lowe
Christopher Lowe CFO @ Cortexyme
CFO
2019-01-01

michael-detke_image

Michael Detke
Michael Detke Chief Medical Officer @ Cortexyme
Chief Medical Officer
2018-12-01

not_available_image

Caryn McDowell
Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary @ Cortexyme
Chief Legal and Administrative Officer and Corporate Secretary
2020-05-01

Founder

casey-lynch_image

Casey Lynch

not_available_image

Kristen Gafric

stephen-dominy_image

Stephen Dominy

Stock Details

Company's stock symbol is NASDAQ:CRTX

Acquisitions List

Date	Company	Article	Price
2022-05-10	Novosteo	Novosteo acquired by Cortexyme	N/A

Investors List

kg-investments_image

Key Employee Changes

Date	New article
2020-04-30	Cortexyme Appoints Caryn McDowell, J.D. as Chief Legal and Administrative Officer and Corporate Secretary

Official Site Inspections

http://www.cortexyme.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.92 K

Host Informations
Whois Informations

Loading ...